| 000 | 01405 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250517121105.0 | ||
| 264 | 0 | _c20170606 | |
| 008 | 201706s 0 0 eng d | ||
| 022 | _a1530-6550 | ||
| 024 | 7 |
_a10.3909/ricm17S1S0002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKrishnan, Sandeep K | |
| 245 | 0 | 0 |
_aAcute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management. _h[electronic resource] |
| 260 |
_bReviews in cardiovascular medicine _c2016 |
||
| 300 |
_aS9-S21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xadverse effects |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aArrhythmias, Cardiac _xdiagnosis |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperkalemia _xblood |
| 650 | 0 | 4 |
_aPolymers _xadverse effects |
| 650 | 0 | 4 |
_aPotassium _xblood |
| 650 | 0 | 4 |
_aRenal Insufficiency, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSilicates _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLepor, Norman E | |
| 773 | 0 |
_tReviews in cardiovascular medicine _gvol. 17 Suppl 1 _gp. S9-S21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3909/ricm17S1S0002 _zAvailable from publisher's website |
| 999 |
_c26503103 _d26503103 |
||